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Abstract
The past 15 years have seen major advances in our understanding
of severity assessment in community-acquired pneumonia (CAP).
Prognostic tools have been promoted to guide all major
management decisions in CAP, including admission to the critical
care unit. Several recent studies, including the study by Renaud
and colleagues, have challenged us to re-evaluate how we
consider severe CAP, a concept for which there is still no
universally accepted definition. Existing severity scores such as the
Pneumonia Severity Index and the CURB65 score are designed to
predict 30-day mortality. As a result, they are heavily weighted by
age and co-morbidity. They perform less well when predicting
other outcomes such as requirement for ICU admission and are of
limited use in the critical care environment. This commentary
discusses recent attempts to develop useful severity criteria to
guide the use of ICU resources in patients with severe CAP.
The past 15 years have seen major advances in our under-
standing of severity assessment in community-acquired pneu-
monia (CAP). Prognostic tools have been promoted to guide
all major management decisions in CAP, including admission
to the critical care unit.
Several recent studies, including the study by Renaud and
colleagues [1], have challenged us to re-evaluate how we
consider severe CAP, a concept for which there is still no
universally accepted definition.
Since the development of the Pneumonia Severity Index in
1997 [2], severe CAP has been considered in terms of a
patient’s risk of 30-day mortality – determined by a combina-
tion of age, co-morbidities and physiological parameters
measured on admission. The two most widely used scores,
the Pneumonia Severity Index and the CURB65 score [3],
were developed to predict 30-day mortality.
It is recognised that the majority of pneumonia mortality
occurs in older people, however, and that many patients who
die are treated palliatively [4]. Nearly 50% of all deaths in
patients with pneumonia and more than one-quarter of deaths
within 30 days are related to co-morbidities rather than being
directly pneumonia related [5].
These scores therefore have important limitations arising from
the use of 30-day mortality as an outcome. The scores may
underestimate severity in young people [6] and they perform
less well when considering outcomes such as intensive care
unit (ICU) admission or requirement for mechanical ventilation
or vasopressor support [7-9]. As few as 20% of patients in
the highest Pneumonia Severity Index class (class V) require
ICU admission, illustrating the system’s limited value for the
critical care community [9].
There is a growing consensus that ICU admission and, more
specifically, mechanical ventilation or vasopressor support
are more useful outcomes than 30-day mortality to define
severe CAP and to identify the most acute ill patients
[7,10-12]. The requirement for mechanical ventilation or vaso-
pressor support is preferred to simply using ICU admission,
as evidence suggests that ICU admission rates and criteria
vary widely across different healthcare systems. This helps to
explain why we see ICU admission rates of 17% in Spain
[13] compared with 8.7% in the UK or 4% in Hong Kong [14].
What scoring system should we used to identify patients
requiring ICU admission? The revised British Thoracic Society
CAP guidelines are due to be published in 2009 and will
recommend using the CURB65 criteria to determine ICU
admission. The Infectious Disease Society of America–
American Thoracic Society guidelines recommend the revised
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American Thoracic Society criteria, which comprise two
major criteria (the requirement for mechanical ventilation and
vasopressor support) or three minor criteria (comprising
respiratory rate, PaO2/FiO2 ratio, multilobar infiltrates, con-
fusion, uraemia, leucopenia, thrombocytopenia, hypothermia
and hypotension requiring aggressive fluid resuscitation)
[15].
Alongside these criteria, Renaud and colleagues [1], Charles
and colleagues [11] and Espana and colleagues [12] have all
independently described scoring systems designed to
predict ICU admission in large databases. It is reassuring that
the high-risk features identified in each of these studies are
similar, with acidosis, systolic blood pressure, respiratory rate,
uraemia, confusion, hypoxaemia and multilobar infiltrates
featuring in each of the derived scores. The abundance of
severity criteria, however, reveals the lack of consensus over
which patients should be initially managed in the ICU.
The majority of admissions to the ICU occur within the first
24 hours. Delayed transfer to the ICU is associated with
increased mortality, and therefore early recognition of these
patients is important. The Risk of Early Admission to Intensive
Care Unit Score has been shown to predict patients with
delayed admission to the ICU. This group probably consists
of patients in whom severity was underestimated on admis-
sion, of patients with treatment failure and of patients with
unstable co-morbidities and nosocomial superinfection.
Further studies in this group are required.
All of the new scores are complex, making them difficult to
implement in clinical practice. Evidence suggests that current
severity criteria, such as the CURB65 score, are under-
utilised. It may therefore be impractical to expect staff to use
the CURB65 score to decide on the site of care, then use
SMART-COP or the American Thoracic Society criteria to
decide whether a patient requires ICU care, and then use the
Risk of Early Admission to Intensive Care Unit Score to
assess their risk of requiring ICU subsequently. A more
practical approach to severity assessment is needed.
A perfect scoring system may not exist, but it should ideally
predict both 30-day mortality and the requirement for
mechanical ventilation or vasopressor support. The scoring
system should be simple, composed of the fewest possible
factors, and easy to remember in a busy emergency depart-
ment. The system should function equally well in older
patients and young patients, and should be based on
physiological derangement and organ dysfunction rather than
on age or co-morbidities. In addition, scoring systems need to
classify patients into distinct management groups.
The hope is that future studies can identify physiological
scoring systems or biomarkers that can achieve these goals
and provide an effective adjunct to clinical judgement in the
early management of CAP.
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